Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Temporal Changes in Clinical Practice with COVID-19 Hospitalized Patients: Potential Explanations for Better In-Hospital Outcomes

View ORCID ProfileKevin E. Kip, View ORCID ProfileGraham Snyder, Donald M. Yealy, View ORCID ProfileJohn W. Mellors, Tami Minnier, View ORCID ProfileMichael P. Donahoe, Jeffrey McKibben, Kevin Collins, View ORCID ProfileOscar C. Marroquin
doi: https://doi.org/10.1101/2020.09.29.20203802
Kevin E. Kip
1Clinical Analytics, University of Pittsburgh Medical Center, Pittsburgh, PA
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kevin E. Kip
  • For correspondence: kipke2{at}upmc.edu
Graham Snyder
2Division of Infectious Diseases, Department of Infection Prevention and Control, University of Pittsburgh School of Medicine, Pittsburgh, PA
MD, SM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Graham Snyder
Donald M. Yealy
3Department of Emergency Medicine, University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center, Pittsburgh, PA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John W. Mellors
4Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John W. Mellors
Tami Minnier
5Wolff Center, University of Pittsburgh Medical Center, Pittsburgh, PA
MSN, RN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael P. Donahoe
6Division of Pulmonary Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael P. Donahoe
Jeffrey McKibben
1Clinical Analytics, University of Pittsburgh Medical Center, Pittsburgh, PA
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin Collins
1Clinical Analytics, University of Pittsburgh Medical Center, Pittsburgh, PA
BSBA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oscar C. Marroquin
1Clinical Analytics, University of Pittsburgh Medical Center, Pittsburgh, PA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Oscar C. Marroquin
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background/Aims We reviewed demographic and clinical profiles, along with measures of hospital-based clinical practice to identify temporal changes in clinical practice that may have affected in-hospital outcomes of patients with COVID-19.

Methods Data consisted of sociodemographic and clinical data captured in University of Pittsburgh Medical Center (UPMC) electronic medical record (EMR) systems, linked by common variables (deidentified). The analysis population included hospitalized patients (across 21 hospitals) with a primary diagnosis of COVID-19 infection during the period March 14-August 31, 2020. The primary outcome was a composite of in-hospital mechanical ventilation/mortality. We compared temporal trends in patient characteristics, clinical practice, and hospital outcomes using 4 time-defined epochs for calendar year 2020: March 14-March 31 (epoch 1); April 1-May 15, (epoch 2), May 16-June 28 (epoch 3); and June 29-August 31 (epoch 4). We report unadjusted survival estimates, followed by propensity score analyses to adjust for differences in patient characteristics, to compare in-hospital outcomes of epoch 4 patients (recently treated) to epoch 1-3 patients (earlier treated).

Results Mean number of hospital admissions was 9.9 per day during epoch 4, which was ∼2-to 3-fold higher than the earlier epochs. Presenting characteristics of the 1,076 COVID-19 hospitalized patients were similar across the 4 epochs, including mean age. The crude rate of mechanical ventilation/mortality was lower in epoch 4 patients (17%) than in epoch 1-3 patients (23% to 35%). When censoring for incomplete patient follow-up, the rate of mechanical ventilation/mortality was lower in epoch 4 patients (p<0.0001), as was the individual component of mechanical ventilation (p=0.0002) and mortality (p=0.02). In propensity score adjusted analyses, the in-hospital relative risk (RR) of mechanical ventilation/mortality was lower in epoch 4 patients (RR=0.67, 95% CI: 0.48, 0.93). For the outcome being discharged alive within 3, 5, or 7 days of admission, adjusted odds ranged from 1.6-to 1.7-fold higher among epoch 4 patients compared to earlier treated patients. The better outcomes in epoch 4 patients were principally observed in patients under the age of 75 years. Patient level dexamethasone use was 55.6% in epoch 4 compared to 15% or less of patients in the earlier epochs. Most patients across epochs received anticoagulation drugs (principally heparin). Overall steroid (81.7% vs. 54.3%, p<0.0001) and anticoagulation use (90.4% vs. 80.7%, p=0.0001) was more frequent on the day or day after hospitalization in epoch 4 patients compared to earlier treated patients.

Conclusions In our large system, recently treated hospitalized COVID-19 patients had lower rates of in-hospital mechanical ventilation/mortality and shorter length of hospital stay. Alongside of this was a change to early initiation of glucocorticoid therapy and anticoagulation. The extent to which the improvement in patient outcomes was related to changes in clinical practice remains to be established.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

Project was not registered as it was a retrospective Quality Improvement project approved by the UPMC Quality Improvement Review Committee

Funding Statement

None.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study received formal ethics approval by the UPMC Ethics and Quality Improvement Review Committee (Project ID 2882), the ethics/oversight body for ensuring patient confidentiality and consent (including waiver of consent) for analysis and dissemination of deidentified data within the UPMC system.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Conflict of Interest Disclosure: None of the authors received any payments or influence from a third-party source for the work presented, and none report any potential conflicts of interest.

  • K.E.K. (kipke2{at}upmc.edu); J.M. (mckijc{at}upmc.edu); K.C. (collinskj{at}upmc.edu); O.C.M (marroquinoc{at}upmc.edu);

  • G.S. (snydergm3{at}upmc.edu)

  • D.M.Y. (yealydm{at}upmc.edu)

  • J.W.M. (jwm1{at}pitt.edu)

  • T.M. (minnierte{at}upmc.edu)

  • M.P.D. donahoem{at}upmc.edu

Data Availability

The data used in this analysis are not available to outside investigators.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 29, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Temporal Changes in Clinical Practice with COVID-19 Hospitalized Patients: Potential Explanations for Better In-Hospital Outcomes
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Temporal Changes in Clinical Practice with COVID-19 Hospitalized Patients: Potential Explanations for Better In-Hospital Outcomes
Kevin E. Kip, Graham Snyder, Donald M. Yealy, John W. Mellors, Tami Minnier, Michael P. Donahoe, Jeffrey McKibben, Kevin Collins, Oscar C. Marroquin
medRxiv 2020.09.29.20203802; doi: https://doi.org/10.1101/2020.09.29.20203802
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Temporal Changes in Clinical Practice with COVID-19 Hospitalized Patients: Potential Explanations for Better In-Hospital Outcomes
Kevin E. Kip, Graham Snyder, Donald M. Yealy, John W. Mellors, Tami Minnier, Michael P. Donahoe, Jeffrey McKibben, Kevin Collins, Oscar C. Marroquin
medRxiv 2020.09.29.20203802; doi: https://doi.org/10.1101/2020.09.29.20203802

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (427)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3284)
  • Dentistry and Oral Medicine (362)
  • Dermatology (275)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1166)
  • Epidemiology (13346)
  • Forensic Medicine (19)
  • Gastroenterology (898)
  • Genetic and Genomic Medicine (5137)
  • Geriatric Medicine (480)
  • Health Economics (781)
  • Health Informatics (3260)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1189)
  • Hematology (428)
  • HIV/AIDS (1015)
  • Infectious Diseases (except HIV/AIDS) (14615)
  • Intensive Care and Critical Care Medicine (910)
  • Medical Education (476)
  • Medical Ethics (126)
  • Nephrology (522)
  • Neurology (4907)
  • Nursing (262)
  • Nutrition (725)
  • Obstetrics and Gynecology (880)
  • Occupational and Environmental Health (795)
  • Oncology (2517)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (540)
  • Pediatrics (1299)
  • Pharmacology and Therapeutics (548)
  • Primary Care Research (554)
  • Psychiatry and Clinical Psychology (4196)
  • Public and Global Health (7488)
  • Radiology and Imaging (1703)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (479)
  • Sexual and Reproductive Health (495)
  • Sports Medicine (424)
  • Surgery (547)
  • Toxicology (72)
  • Transplantation (235)
  • Urology (203)